Olema director awarded stock options at $14.59
Olema Pharmaceuticals director Raman Prakash received two stock option grants as equity compensation.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Olema Pharmaceuticals director Raman Prakash received two stock option grants as equity compensation. The awards cover a combined 27,061 shares of common stock at an exercise price of $14.59 per share, expiring on April 27, 2036.
Options on 24,150 shares vest in full on June 11, 2026, while options on 2,911 shares vest in 36 equal monthly installments starting April 28, 2026. All vesting is conditioned on Prakash’s continuous service with the company.
Insider Trade Summary
Grant/Award: 27,061 shares
Grant/Award
2 txns
Insider
Raman Prakash
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 2,911 | $0.00 | $0.00 |
| Grant/Award | Stock Option (Right to Buy) | 24,150 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (Right to Buy) — 27,061 contracts (Direct)
Footnotes (2)
- F1. The shares subject to the option vest in full on June 11, 2026, subject to the Reporting Person's continuous service through such vesting date.
- F2. The shares subject to the option vest in a series of 36 successive equal monthly installments measured from April 28, 2026, subject to the Reporting Person's continuous service through each applicable vesting date.
Key Figures
Option grant size 1: 24,150 options
Option grant size 2: 2,911 options
Total options granted: 27,061 options
+4 more
7 metrics
Option grant size 1
24,150 options
Stock Option (Right to Buy) on Common Stock
Option grant size 2
2,911 options
Stock Option (Right to Buy) on Common Stock
Total options granted
27,061 options
Combined derivative awards to director
Exercise price
$14.59 per share
Conversion or exercise price for both option grants
Expiration date
April 27, 2036
Option term end date for both grants
Cliff vesting date
June 11, 2026
24,150-share grant vests in full on this date
Monthly vesting schedule
36 monthly installments
2,911-share grant vests from April 28, 2026
Key Terms
Stock Option (Right to Buy), Common Stock, exercise price, vesting, +1 more
5 terms
Stock Option (Right to Buy) financial
"security_title: Stock Option (Right to Buy)"
Common Stock financial
"underlying_security_title: Common Stock"
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
exercise price financial
"conversion_or_exercise_price: 14.5900"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vesting financial
"The shares subject to the option vest in full on June 11, 2026"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
continuous service financial
"subject to the Reporting Person's continuous service through such vesting date"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Olema Pharmaceuticals (OLMA) director Raman Prakash receive in this Form 4 filing?
Raman Prakash received two grants of stock options as equity compensation, covering a total of 27,061 shares of Olema common stock at an exercise price of $14.59 per share, with vesting tied to his continued service with the company.
What are the key terms of Raman Prakash’s Olema (OLMA) stock option awards?
The options allow Prakash to buy 27,061 Olema common shares at $14.59 per share until April 27, 2036. One grant vests all at once on June 11, 2026, and the other vests in 36 equal monthly installments starting April 28, 2026.
How do the Olema (OLMA) stock options granted to Raman Prakash vest over time?
Options on 24,150 shares vest in full on June 11, 2026. Options on 2,911 shares vest in 36 equal monthly installments beginning April 28, 2026. Each vesting tranche requires Prakash to remain in continuous service through the applicable vesting date.
Are Raman Prakash’s Olema (OLMA) stock option grants open-market purchases or compensation?
These transactions are compensation-related stock option grants, not open-market share purchases. The options were awarded at a grant price of $0.00, carry a $14.59 exercise price, and become exercisable only as they vest based on Prakash’s continuing service.
When do the Olema (OLMA) stock options granted to director Raman Prakash expire?
Both stock option grants reported for Raman Prakash share the same expiration date of April 27, 2036. He can exercise vested options at $14.59 per share any time before expiration, subject to Olema’s equity plan and applicable service conditions.
AI-generated analysis. How Rhea-AI works. Not financial advice.
